Healthcare company Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to pharmaceutical company Pfizer for a total cash consideration of $635 million, subject to certain adjustments. [ + ]

ResMed (ASX:RMD) has reported a 20% growth in profit but flat revenue for the fourth quarter, and reported the results of a successful study into using NPPH to treat advanced COPD. [ + ]

Who do you think are the industry's high achievers? The annual Industry Excellence Awards celebrate the individuals and organisations that have made a significant contribution to the biotechnology industry and, through their leadership, continue to make a difference to the growth of the bio-economy. The recipients of these prestigious awards are at the forefront of thriving biotech, innovation and healthcare sectors in Australia. [ + ]

US physicians have identified a potential new market for Osprey's AVERT system, which is designed to help protect the kidneys from toxic dyes used in X-ray imaging. [ + ]

QFAB Bioinformatics and the Garvan Institute of Medical Research will combine their capabilities to offer human genome sequence data analysis for scientists and clinicians. [ + ]

Weather Detective, an online citizen science project, is seeking assistance to help uncover important weather records hidden in the log books of ships that sailed the seas around Australia in the 1890s and 1900s. [ + ]

ARTES Biotechnology and the Burnet Institute are collaborating to develop a new type of malaria vaccine in a project funded by the PATH Malaria Vaccine Initiative (MVI). The project will focus on strategies to produce vaccines that can block the transmission of malaria infection from mosquitoes to people. [ + ]

Academics from Trinity College Dublin have shed light on the market dynamics and potential in licensing deals with big pharmaceutical companies. Their findings are of particular relevance to those working in and funding drug development worldwide. [ + ]

pSivida (ASX:PVA) revealed its licensee Alimera has won approval in Norway and Denmark, and reimbursement in Portugal, for diabetic macular oedema treatment Iluvien. [ + ]

This year's Jeans for Genes Day marks the 21st year of a campaign that provides much-needed support for research, such as the development of a pharmacological toolkit for researchers. [ + ]

Australian wattles have evolved the ability to survive and thrive in salty and alkaline soils numerous times, with several species able to tolerate high levels of both. [ + ]

Melbourne is about to host the next International Association for Plant Biotechnology (IAPB) Congress 2014. [ + ]

Forensic scientist Anna Bradley is undertaking the world's largest bullet lead study, building on research the FBI started when US President John F Kennedy was assassinated in 1963. Bradley is looking to track the unique 'fingerprint' of bullets in the hope of solving crimes. [ + ]

Market research company Roy Morgan Research has found that consumers are making the shift towards cruelty-free beauty products. The findings align with the news that the Australian Labor Party is currently consulting with the public on the possibility of phasing out the importation, manufacture, sale and advertising of cosmetics or cosmetic ingredients tested on animals. [ + ]

Biopharma company Redbiotec and multinational GE Healthcare Life Sciences are collaborating on a process which could lead to the development and production of new vaccines against cytomegalovirus (CMV). [ + ]